🔺 What to do when markets are at an all-time high? Find smart bargains, like these.See Undervalued Stocks

Revvity Inc (RVTY)

NYSE
Currency in USD
116.46
+1.37(+1.19%)
Closed
Pre Market
116.79+0.33(+0.28%)
RVTY Scorecard
Full Analysis
Management has been aggressively buying back shares
Fair Value
Day's Range
115.65117.54
52 wk Range
88.90129.50
Key Statistics
Edit
Prev. Close
116.46
Open
115.81
Day's Range
115.65-117.54
52 wk Range
88.9-129.5
Volume
709.62K
Average Volume (3m)
834.91K
1-Year Change
27.95%
Book Value / Share
unlockUnlock
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
RVTY Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
138.68
Upside
+19.08%
Members' Sentiments
Bearish
Bullish
ProTips
High shareholder yield
Show more

Revvity Inc Company Profile

Revvity, Inc. provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. This segment also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for applications in oncology, immunodiagnostics, and drug discovery. It serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies under the AutoDELFIA, BACS-on-Beads, BIOCHIPs, Bioo Scientific,BoBs , chemagic, Chitas, DELFIA, DELFIA Xpress, DOPlify, EONIS, EUROArray, EUROIMMUN, EUROLabWorkstation, EUROLINE, EUROPattern, Evolution Evoya, explorer, Fontus, Genoglyphix, GSP, Haoyuan, IDS, IDS-i10 IDS-i10T, IDS-iSYS, iLab, iQ, JANUS, LabChip, LifeCycle, LimsLink, Migele, MultiPROBE, NEXTFLEX, NextPrep, Pannoramic, Panthera Puncher, PG-Seq, PGFind PKamp, PreNAT II, Prime, Protein Clear, ProteinEXact, QSigh, QuantiVac, RONIA, Sciclone, SimplicityChrom, Specimen Gate,Superflex, Symbio, T-SPOT, Touch, Twister, Vanadis, VariSpec, ViaCord VICTOR 2D, and Zephyr brand name. The company was formerly known as PerkinElmer, Inc. and changed its name to Revvity, Inc. in April 2023. Revvity, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.

Compare RVTY to Peers and Sector

Metrics to compare
RVTY
Peers
Sector
Relationship
P/E Ratio
54.9x84.8x−0.7x
PEG Ratio
−0.84−1.360.00
Price/Book
1.8x3.4x2.6x
Price / LTM Sales
5.2x4.5x3.2x
Upside (Analyst Target)
18.5%15.2%47.0%
Fair Value Upside
Unlock−5.9%7.5%Unlock

Analysts' Recommendations

13 Buy
7 Hold
0 Sell
Ratings:
18 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 138.68

(+19.08% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 2.06
Dividend Yield
0.24%
Industry Median 0.73%
Annualized payout
0.2800
Paid quarterly
5-Years Growth
-
Growth Streak

People Also Watch

253.63
CEG
-0.96%
62.25
TPR
-1.53%
77.72
DXCM
-1.52%
157.78
BIIB
-0.93%

FAQ

What Is the Revvity (RVTY) Stock Price Today?

The Revvity stock price today is 116.46

What Stock Exchange Does Revvity Trade On?

Revvity is listed and trades on the NYSE stock exchange.

What Is the Stock Symbol for Revvity?

The stock symbol for Revvity is "RVTY."

Does Revvity Pay Dividends? What’s The Current Dividend Yield?

The Revvity dividend yield is 0.24%.

What Is the Revvity Market Cap?

As of today, Revvity market cap is 14.17B.

What is Revvity Earnings Per Share?

The Revvity EPS is 2.06.

What Is the Next Revvity Earnings Date?

Revvity will release its next earnings report on Jan 28, 2025.

From a Technical Analysis Perspective, Is RVTY a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.